-- Online-First Publication Currently Available -- -- First Randomized Trial With Survival Endpoint in ...
The $1.8 million U.S. National Cancer Institute (NCI) grant, awarded to the Medical University ...
Encouraging initial anti-leukemic activity with durable responses and acceptable tolerability observed in dose expansion ...
